IOAPX
Price
$24.27
Change
-$0.02 (-0.08%)
Updated
Apr 17 closing price
Net Assets
1.33B
VITSX
Price
$125.99
Change
+$0.29 (+0.23%)
Updated
Apr 17 closing price
Net Assets
1.7T
Ad is loading...

IOAPX vs VITSX

Header iconIOAPX vs VITSX Comparison
Open Charts IOAPX vs VITSXBanner chart's image
Invesco Main Street All Cap R6
Price$24.27
Change-$0.02 (-0.08%)
VolumeN/A
Net Assets1.33B
Vanguard Total Stock Market Idx I
Price$125.99
Change+$0.29 (+0.23%)
VolumeN/A
Net Assets1.7T
IOAPX vs VITSX Comparison Chart
Loading...
View a ticker or compare two or three
VS
IOAPX vs. VITSX commentary
Apr 18, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IOAPX is a Buy and VITSX is a Buy.

Ad is loading...
FUNDAMENTALS
Fundamentals
VITSX has more cash in the bank: 1.7T vs. IOAPX (1.33B). VITSX pays higher dividends than IOAPX: VITSX (1.36) vs IOAPX (0.82). IOAPX was incepted earlier than VITSX: IOAPX (6 years) vs VITSX (28 years). IOAPX (0.73) is less costly to investors than VITSX (0.03). IOAPX is a more actively managed with annual turnover of: 54.00 vs. VITSX (2.00). IOAPX has a lower initial minimum investment than VITSX: IOAPX (1000000) vs VITSX (5000000). VITSX annual gain was more profitable for investors over the last year : 4.35 vs. IOAPX (-0.48). VITSX return over 5 years is better than : 80.96 vs. IOAPX (46.02).
IOAPXVITSXIOAPX / VITSX
Total Expense Ratio0.730.032,433%
Annual Report Gross Expense Ratio0.730.032,433%
Fund Existence6 years28 years-
Gain YTD-7.909-10.85473%
Front LoadN/AN/A-
Min. Initial Investment1000000500000020%
Min. Initial Investment IRAN/AN/A-
Net Assets1.33B1.7T0%
Annual Yield % from dividends0.821.3660%
Returns for 1 year-0.484.35-11%
Returns for 3 years9.1517.5552%
Returns for 5 years46.0280.9657%
Returns for 10 yearsN/A146.15-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ESCA14.820.27
+1.86%
Escalade
SABS1.390.01
+0.72%
SAB Biotherapeutics
PLXS121.92-0.26
-0.21%
Plexus Corp
CE37.53-0.40
-1.05%
Celanese Corp
ENFN10.80-0.12
-1.10%
Enfusion